Disease-Modifying Antirheumatic Drugs and Remote Ischemic Postconditioning Ameliorate for Myocardial Injury in Rats Under Cerebral Stroke

Disease-Modifying Antirheumatic Drugs and Remote Ischemic Postconditioning Ameliorate for Myocardial Injury in Rats Under Cerebral Stroke

Objective: Currently, there is uncertainty about the increased risk of myocardial infarction following ischemic stroke or transient ischemic attack and the method of risk management after the stroke. In this experimental study, we aimed to evaluate myocardial injury after inducing global cerebral is...

Full description

Bibliographic Details
Main Authors:	Duygun Altıntaş Aykan, Muhammed Seyithanoğlu, Ülkü Kazancı
Format:	Article
Language:	English
Published:	KARE Publishing 2019-11-01
Series:	Erciyes Medical Journal
Subjects:	ischemia-reperfusion injury myocardial infarct cerebral stroke disease-modifying antirheumatic drugs.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=erciyesmedj&un=EMJ-02703

Similar Items

Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
by: Nancy Schanze, et al.
Published: (2019-06-01)

Phenylephrine postconditioning increases myocardial injury: Are alpha-1 sympathomimetic agonist cardioprotective?
by: Iordanis Mourouzis, et al.
Published: (2014-01-01)

Postconditioning as a method tissue survivability enhancement in ischemic damage
by: M. G. Shurygin, et al.
Published: (2016-07-01)

Protective Effect of Delayed Ischemic Postconditioning on Embolic Stroke Complications in Female Rat
by: M Mobini, et al.
Published: (2014-06-01)

Ischemic postconditioning fails to reduce infarct size in pig models of intermediate and prolonged ischemia
by: Jorge Nuche, et al.
Published: (2023-02-01)

Adenosine in Acute Myocardial Infarction-Associated Reperfusion Injury: Does it Still Have a Role?
by: Corrado De Marco, et al.
Published: (2022-05-01)

Mechanical complications of myocardial infarction: basic aspects of pathogenesis and approaches to surgical treatment
by: L. D. Shengelia, et al.
Published: (2023-07-01)

An Overview of the Molecular Mechanisms Associated with Myocardial Ischemic Injury: State of the Art and Translational Perspectives
by: Leonardo Schirone, et al.
Published: (2022-03-01)

Effects of IL-38 on Macrophages and Myocardial Ischemic Injury
by: Zhiyang Li, et al.
Published: (2022-05-01)

The Role of Autophagy in Acute Myocardial Infarction
by: Du Wu, et al.
Published: (2019-05-01)

Exercise training and experimental myocardial ischemia and reperfusion: A systematic review and meta-analysis
by: Eduardo Carvalho de Arruda Veiga, et al.
Published: (2023-06-01)

Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01)

Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model
by: Maria J. Sebastião, et al.
Published: (2019-03-01)

THE EFFECTIVENESS OF PRECONDITIONING AND POSTCONDITIONING WITH ADENOSINE IN PREVENTION OF REPERFUSION DAMAGE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: N. T. Vatutin, et al.
Published: (2018-02-01)

Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential
by: Jamie Francisco, et al.
Published: (2023-10-01)

Combined use of ischemic preconditioning and postconditioning in a skin flap model in rats
by: Asim Uslu, et al.
Published: (2019-01-01)

Disease-modifying antirheumatic drugs – Old and new: A brief overview
by: Vidya Divakar Baliga, et al.
Published: (2019-01-01)

Transcriptome analysis reveals ADAMTS15 is a potential inflammation-related gene in remote ischemic postconditioning
by: Bo Zuo, et al.
Published: (2023-05-01)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01)

Topical Neck Cooling Without Systemic Hypothermia Attenuates Myocardial Ischemic Injury and Post-ischemic Reperfusion Injury
by: Aimee Zhang, et al.
Published: (2022-06-01)

Larger infarct size but equal protection by ischemic conditioning in septum and anterior free wall of pigs with LAD occlusion
by: Andreas Skyschally, et al.
Published: (2019-10-01)

Reperfusion therapy for acute myocardial infarction /
by: Bates, Eric R.
Published: (2008)

Postconditioning with lactate-enriched blood in ST-segment elevation myocardial infarction
by: Takashi Koyama, et al.
Published: (2022-12-01)

SUMOylation as a Therapeutic Target for Myocardial Infarction
by: Wei Zhao, et al.
Published: (2021-07-01)

Myocardial infarct size is reduced by nitrite and nitrate administration
by: Younes Yassaghi, et al.
Published: (2024-01-01)

Oxidative stress and its association with ST resolution and clinical outcome measures in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention
by: Elmira Matin, et al.
Published: (2020-11-01)

Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury
by: Chiu-Fen Yang
Published: (2018-01-01)

Transfusion of Plasma Collected at Late Phase after Preconditioning Reduces Myocardial Infarct Size Induced by Ischemia-reperfusion in Rats In vivo
by: Yang Zhao, et al.
Published: (2017-01-01)

Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies
by: Niek J. Pluijmert, et al.
Published: (2021-04-01)

There is no consensus on the myocardial ischemia/reperfusion injury induction methods in animal studies
by: Koohyar Ahmadzadeh, et al.
Published: (2023-04-01)

Downregulation of Gldc attenuates myocardial ischemia reperfusion injury in vitro by modulating Akt and NF-κB signalings
by: Lian Shuang, et al.
Published: (2025-01-01)

Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarizationResearch in context
by: Lingfang Zhuang, et al.
Published: (2023-09-01)

Lebetin 2, a Snake Venom-Derived B-Type Natriuretic Peptide, Provides Immediate and Prolonged Protection against Myocardial Ischemia-Reperfusion Injury via Modulation of Post-Ischemic Inflammatory Response
by: Bochra Tourki, et al.
Published: (2019-09-01)

Protective Effects of Adrenomedullin on Rat Cerebral Tissue After Transient Bilateral Common Carotid Artery Occlusion and Reperfusion
by: Mehmet Kirisci, et al.

Comparison of infarction size, complete ST-segment resolution incidence, mortality and re-infarction and target vessel revascularization between remote ischemic conditioning and ischemic postconditioning in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Haozhou Zhang, et al.
Published: (2020-10-01)

The Signaling Mechanism of Remote Postconditioning of the Heart: Prospects of the Use of Remote Postconditioning for the Treatment of Acute Myocardial Infarction
by: Vyacheslav V. Ryabov, et al.
Published: (2023-06-01)

Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies
by: Panat Yanpiset, et al.
Published: (2023-01-01)

Innate Lymphoid Cells and Myocardial Infarction
by: Wenling Yang, et al.
Published: (2021-11-01)

Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives
by: Lejla Medzikovic, et al.
Published: (2023-08-01)

Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction
by: Cory Trankle, MD, et al.
Published: (2016-10-01)